Robbins Wendye's Form 4 filing
RAPT Therapeutics, Inc. (RAPT) · filed May 12, 2022
- Accession no.
- 0001593968-22-000958
- Filed
- May 12, 2022
- Trade date
- May 10, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions. Open-market purchases total $77.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Robbins WendyeCIK 0001791244 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 10, 2022 | Common Stock | PPurchaseAcquired | +2,000 | $10.54 | +$21,080 | 11,300 | Direct | |
| May 10, 2022 | Common Stock | PPurchaseAcquired | +2,500 | $11.80 | +$29,500 | 13,800 | Direct | |
| May 10, 2022 | Common Stock | PPurchaseAcquired | +500 | $11.30 | +$5,650 | 1,800 | Indirect | |
| May 10, 2022 | Common Stock | PPurchaseAcquired | +1,000 | $10.51 | +$10,510 | 3,000 | Indirect | |
| May 10, 2022 | Common Stock | PPurchaseAcquired | +600 | $10.49 | +$6,294 | 3,600 | Indirect | |
| May 10, 2022 | Common Stock | PPurchaseAcquired | +400 | $10.62 | +$4,248 | 4,000 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.